Response to Imatinib in a Patient With Gastric Adenocarcinoma With <i>KIT</i> Q556_K558 In-Frame Deletion: A Case Report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39298692.
- Also identified by DOI 10.1200/PO.24.00228.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Imatinib may be a useful targeted agent for patients with advanced gastric adenocarcinoma who have KIT mutations.
Medical subject headings
- Adenocarcinoma
- Imatinib Mesylate
- Proto-Oncogene Proteins c-kit
- Stomach Neoplasms